CN113563258A - Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine - Google Patents

Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine Download PDF

Info

Publication number
CN113563258A
CN113563258A CN202110860726.2A CN202110860726A CN113563258A CN 113563258 A CN113563258 A CN 113563258A CN 202110860726 A CN202110860726 A CN 202110860726A CN 113563258 A CN113563258 A CN 113563258A
Authority
CN
China
Prior art keywords
compound
reaction
difluoromethyl
bromo
methylpyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110860726.2A
Other languages
Chinese (zh)
Inventor
蒋红亮
王力刚
史洪亮
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Paipu Pharmaceutical Jiangsu Co ltd
Original Assignee
Paipu Pharmaceutical Jiangsu Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Paipu Pharmaceutical Jiangsu Co ltd filed Critical Paipu Pharmaceutical Jiangsu Co ltd
Priority to CN202110860726.2A priority Critical patent/CN113563258A/en
Publication of CN113563258A publication Critical patent/CN113563258A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine. The preparation method takes the compound A as a raw material, and the 4-bromo-2- (difluoromethyl) -5-methylpyridine is prepared through oxidation reaction, nitration reaction, substitution reaction, reduction reaction, hydrolysis reaction, oxidation reaction and fluorination reaction in sequence.

Description

Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine
Technical Field
The invention belongs to the technical field of medical intermediates, and particularly relates to a preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine.
Background
4-bromo-2- (difluoromethyl) -5-methylpyridine is a very important fluorine-containing pyridine intermediate, and is a common intermediate for synthesizing pharmaceutical compounds and pesticide compounds. Few methods for the synthesis of this compound have been reported in the prior art. Therefore, it is highly desirable to provide a method for synthesizing 4-bromo-2- (difluoromethyl) -5-methylpyridine.
Disclosure of Invention
The technical problems to be solved by the invention are as follows: in view of the above problems, a process for producing 4-bromo-2- (difluoromethyl) -5-methylpyridine is provided.
In order to solve the technical problems, the invention adopts the following technical scheme:
a preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine comprises the following steps:
(1) and (3) oxidation reaction: the compound A, m-CPBA is subjected to oxidation reaction in an organic solvent to obtain a compound B
Figure DEST_PATH_IMAGE001
(2) Nitration reaction: carrying out nitration reaction on the compound B and nitric acid in the environment of concentrated sulfuric acid to obtain a compound C
Figure 311596DEST_PATH_IMAGE002
(3) And (3) substitution reaction: carrying out substitution reaction on the compound C, acetic acid and acetyl chloride to obtain a compound D
Figure DEST_PATH_IMAGE003
(4) Reduction reaction: carrying out reduction reaction on the compound D and acetic anhydride to obtain a compound E
Figure 635261DEST_PATH_IMAGE004
(5) And (3) hydrolysis reaction: mixing the compound E and hydrochloric acid, and carrying out hydrolysis reaction to obtain a compound F
Figure DEST_PATH_IMAGE005
(6) And (3) oxidation reaction: carrying out oxidation reaction on the compound F and manganese dioxide in an organic solvent to obtain a compound G
Figure 601949DEST_PATH_IMAGE006
(7) And (3) fluoro reaction: mixing the compound G, DAST and DCM for carrying out fluoro reaction to obtain 4-bromo-2- (difluoromethyl) -5-methylpyridine
Figure DEST_PATH_IMAGE007
Preferably, the specific operation of the step (1) is to take the compound A according to the mass ratio of the compound A, m-CPBA of 1: 2-4, firstly put the compound A into a reactor, add chloroform to completely dissolve the compound A, set the temperature to be 0-2 ℃, add m-CPBA, heat to room temperature, react overnight, and obtain the compound B.
Preferably, the specific operation of the step (2) is to take the compound B and a nitric acid solution according to the mass ratio of 1: 1-3, put the compound B in concentrated sulfuric acid, stir the mixture evenly, add the nitric acid solution at 0-2 ℃, heat the mixture to room temperature, perform heat preservation reaction, and heat the mixture again to obtain the compound C.
Preferably, the specific operation in the step (3) is to take the compound C and acetyl bromide according to the mass ratio of 1: 6-10, mix the compound C and acetic acid according to the solid-liquid g/mL ratio of 1:10, add acetyl bromide at 0 ℃, heat, stir and react to obtain the compound D.
Preferably, the specific operation of the step (4) is to mix the compound D and acetic anhydride according to the mass ratio of 1: 2-4, carry out nitrogen protection, heat up, and react to obtain the compound E.
Preferably, the specific operation of the step (5) is to mix the compound E and hydrochloric acid according to a solid-liquid g/mL ratio of 1:10, and react to obtain the compound F.
Preferably, the specific operation of the step (6) is to mix the compound F and manganese dioxide according to the mass ratio of 1: 4-6, place the mixture in dichloromethane, and stir for reaction to obtain the compound G.
Preferably, the specific operation of the step (7) is to put the compound G in DCM, add DAST 2-3 times the mass of the compound G, and stir to react to obtain 4-bromo-2- (difluoromethyl) -5-methylpyridine.
Compared with other methods, the method has the beneficial technical effects that:
the preparation method takes the compound A as a raw material, and the 4-bromo-2- (difluoromethyl) -5-methylpyridine is prepared through oxidation reaction, nitration reaction, substitution reaction, reduction reaction, hydrolysis reaction, oxidation reaction and fluorination reaction in sequence.
Detailed Description
A method for preparing 4-bromo-2- (difluoromethyl) -5-methylpyridine, which comprises
(1) Taking materials according to the mass ratio of the compound A, m-CPBA of 1: 2-4, firstly putting the compound A into a reactor, adding chloroform to completely dissolve the compound A, setting the temperature to be 0-2 ℃, adding m-CPBA, heating to room temperature, and reacting overnight to obtain a compound B;
(2) taking a compound B and a nitric acid solution according to the mass ratio of 1: 1-3, putting the compound B into concentrated sulfuric acid, uniformly stirring, adding the nitric acid solution at 0-2 ℃, heating to room temperature, carrying out heat preservation reaction, and heating again for reaction to obtain a compound C;
(3) taking the compound C and acetyl bromide according to the mass ratio of 1: 6-10, mixing the compound C and acetic acid according to the solid-liquid g/mL ratio of 1:10, adding the acetyl bromide at 0 ℃, heating, and stirring for reaction to obtain a compound D.
(4) And mixing the compound D and acetic anhydride according to the mass ratio of 1: 2-4, carrying out nitrogen protection, heating, and reacting to obtain a compound E.
(5) And mixing the compound E and hydrochloric acid according to the solid-liquid g/mL ratio of 1:10, and reacting to obtain a compound F.
(6) Mixing the compound F and manganese dioxide according to the mass ratio of 1: 4-6, placing the mixture into dichloromethane, and stirring to react to obtain a compound G;
(7) and (3) placing the compound G into DCM, adding DAST with the mass of 2-3 times of that of the compound G, and stirring for reaction to obtain the 4-bromo-2- (difluoromethyl) -5-methylpyridine.
In the preparation process: DCM is dichloromethane; DAST is diethylaminosulfur trifluoride; m-CPBA is m-chloroperoxybenzoic acid.
In order to make the objects, technical solutions and advantages of the present invention more clear, the present invention is further described with reference to the following embodiments:
example 1
A method for preparing 4-bromo-2- (difluoromethyl) -5-methylpyridine, which comprises
(1) Adding 20g of compound A and 400mL of chloroform into a reaction bottle, stirring for dissolving, cooling to 0 ℃ in an ice water bath, adding 40gm-CPBA (at least 30 min), slowly heating to normal temperature for reacting overnight, detecting by TLC, reacting the raw materials, and adding saturated Na2SO3The solution was stirred for 1h to quench m-CPBA and saturated NaHCO was added3The organic layer was washed 3 times with the solution, and after washing, the sample was stirred and passed through a column, about n-hexane: the product yield is 18.8g of colorless transparent oily matter when the ethyl acetate is =1:1, namely the compound B with the purity of 97.8 percent;
(2) adding 200mL of concentrated sulfuric acid into a reaction bottle, slowly adding 18g of compound B in an ice-water bath, slowly adding 18g of nitric acid solution (mass fraction of 65%) at 0 ℃ after dripping, heating to room temperature for reaction for 1h after dripping, heating to 110 ℃ for reaction for 72h, detecting by TLC, slowly pouring the reaction solution into ice water, extracting by using dichloromethane 300mL X5, mixing the sample and passing through a column, and adding n-hexane: the product is obtained when ethyl acetate =3:1, 17.9g of yellow solid is obtained, namely the compound C, and the purity is 98.3%;
(3) adding 180mL of acetic acid and 18g of the compound C into a reaction bottle, slowly dropwise adding 108g of acetyl bromide under stirring at 0 ℃, heating to 80 ℃ for reaction for 4 hours after dropwise addition, pouring the reaction solution into ice water after TLC detection reaction, extracting dichloromethane with 200mL of X5, concentrating the organic layer under reduced pressure, and spin-drying to obtain a yellow brown solid, namely compound D with the purity of 98.2%;
(4) adding 18g of the compound D and 36g of acetic anhydride into a reaction bottle, performing nitrogen replacement for 3 times, heating to 110 ℃ under the protection of nitrogen, reacting for 2 hours, pouring the reaction liquid into ice water after TLC detection reaction is finished, extracting with ethyl acetate, and spin-drying to obtain 15.3g of colorless transparent oily substance, namely the compound E, wherein the purity is 98.1%;
(5) adding 14g of compound E and 140mL of hydrochloric acid (3M) into a reaction flask, stirring for reaction for 2h, and detecting by TLC, wherein NaHCO is used for detection after the reaction is finished3Adjusting the pH value of the solid to be alkalescent, extracting by ethyl acetate, and spin-drying the organic phase to obtain 12.2g of solid with the purity of 98.9 percent;
(6) adding 12G of compound F, 48G of manganese dioxide and 250mL of dichloromethane into a reaction bottle, stirring at room temperature overnight, detecting by TLC, filtering, spin-drying filtrate to obtain a dark gray solid, and purifying by a column to obtain 9.3G of yellow solid, namely compound G with the purity of 97.6%;
(7) adding 5G of compound G and 50mL of DCCM into a reaction flask, reducing the temperature to-78 ℃ under the protection of nitrogen, keeping the temperature, slowly adding 10G of DAST dropwise after finishing dropping, slowly increasing the temperature to room temperature, reacting overnight, detecting the reaction by TLC, pouring the reaction solution into ice water (150 mL), extracting 3 times with ethyl acetate (100 mL x 2), mixing the sample with silica gel, passing through a column, and obtaining n-hexane: ethyl acetate =5:1 to give the product, which was spin-dried to give 4.1g of a colorless transparent oil with a purity of 98.8%.
Nuclear magnetic data: 1H NMR (d 6-DMSO) 8.62(s, 1H), 7.95(s, 1H), 6.96(t, J =54.4Hz, 1H),2.40(s, 3H).
Example 2
A method for preparing 4-bromo-2- (difluoromethyl) -5-methylpyridine, which comprises
(1) Adding 20g of compound A and 400mL of chloroform into a reaction bottle, stirring for dissolving, cooling to 0 ℃ in an ice water bath, adding 80gm-CPBA (at least 30 min), slowly heating to normal temperature for reacting overnight, detecting by TLC, reacting the raw materials, and adding saturated Na2SO3The solution was stirred for 1h to quench m-CPBA and saturated NaHCO was added3The organic layer was washed 3 times with the solution, and after washing, the sample was stirred and passed through a column, about n-hexane: when the ethyl acetate =1:1, 19.2g of colorless transparent oily substance is obtained, namely the compound B with the purity of 98.2 percent;
(2) adding 200mL of concentrated sulfuric acid into a reaction bottle, slowly adding 18g of compound B in an ice-water bath, slowly adding 54g of nitric acid solution (mass fraction of 65%) at 0 ℃ after dripping, heating to room temperature for reaction for 1h after dripping, heating to 110 ℃ for reaction for 72h, detecting by TLC, slowly pouring the reaction solution into ice water, extracting by using dichloromethane 300mL X5, mixing the sample with a sample, passing through a column, and adding n-hexane: the product is obtained when ethyl acetate =3:1, 18.1g of yellow solid is obtained, namely the compound C, and the purity is 99.2%;
(3) adding 180mL of acetic acid and 18g of the compound C into a reaction bottle, slowly dropwise adding 180g of acetyl bromide under stirring at 0 ℃, heating to 80 ℃ for reaction for 4 hours after dropwise addition, pouring the reaction solution into ice water after TLC detection reaction, extracting dichloromethane with 200mL of X5, concentrating the organic layer under reduced pressure, and spin-drying to obtain a yellow brown solid, namely compound D with the purity of 98.1%;
(4) adding 18g of the compound D and 76g of acetic anhydride into a reaction bottle, performing nitrogen replacement for 3 times, heating to 110 ℃ under the protection of nitrogen, reacting for 2 hours, pouring the reaction liquid into ice water after TLC detection reaction is finished, extracting with ethyl acetate, and spin-drying to obtain 16.0g of colorless transparent oily substance, namely the compound E, wherein the purity is 98.2%;
(5) adding 14g of compound E and 140mL of hydrochloric acid (3M) into a reaction flask, stirring for reaction for 2h, and detecting by TLC, wherein NaHCO is used for detection after the reaction is finished3Adjusting the pH value of the solid to be alkalescent, extracting by ethyl acetate, and spin-drying the organic phase to obtain 12.2g of solid with the purity of 98.9 percent;
(6) adding 12G of compound F, 72G of manganese dioxide and 250mL of dichloromethane into a reaction bottle, stirring overnight at room temperature, performing TLC detection reaction, filtering, spin-drying filtrate to obtain a dark gray solid, and performing column purification to obtain 10.1G of yellow solid, namely compound G with the purity of 98.2%;
(7) adding 5G of compound G and 50mL of DCCM into a reaction flask, reducing the temperature to-78 ℃ under the protection of nitrogen, keeping the temperature, slowly adding 15G of DAST dropwise after finishing dropping, slowly increasing the temperature to room temperature, reacting overnight, detecting the reaction by TLC, pouring the reaction solution into ice water (150 mL), extracting 3 times with ethyl acetate (100 mL x 2), mixing the sample with silica gel, passing through a column, and obtaining n-hexane: ethyl acetate =5:1 to give the product, which was spin-dried to give 5.3g of a colorless transparent oil with a purity of 99.1%.
Nuclear magnetic data: 1H NMR (d 6-DMSO) 8.62(s, 1H), 7.95(s, 1H), 6.96(t, J =54.4Hz, 1H),2.40(s, 3H).

Claims (8)

1. A preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine is characterized by comprising the following steps:
(1) and (3) oxidation reaction: the compound A, m-CPBA is subjected to oxidation reaction in an organic solvent to obtain a compound B
Figure DEST_PATH_IMAGE002
(2) Nitration reaction: carrying out nitration reaction on the compound B and nitric acid in the environment of concentrated sulfuric acid to obtain a compound C
Figure DEST_PATH_IMAGE004
(3) And (3) substitution reaction: carrying out substitution reaction on the compound C, acetic acid and acetyl chloride to obtain a compound D
Figure DEST_PATH_IMAGE006
(4) Reduction reaction: carrying out reduction reaction on the compound D and acetic anhydride to obtain a compound E
Figure DEST_PATH_IMAGE008
(5) And (3) hydrolysis reaction: mixing the compound E and hydrochloric acid, and carrying out hydrolysis reaction to obtain a compound F
Figure DEST_PATH_IMAGE010
(6) And (3) oxidation reaction: carrying out oxidation reaction on the compound F and manganese dioxide in an organic solvent to obtain a compound G
Figure DEST_PATH_IMAGE012
(7) And (3) fluoro reaction: mixing the compound G, DAST and DCM for carrying out fluoro reaction to obtain 4-bromo-2- (difluoromethyl) -5-methylpyridine
Figure DEST_PATH_IMAGE014
2. The preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the step (1) is specifically carried out by taking a compound A, m-CPBA in a mass ratio of 1: 2-4, first putting the compound A into a reactor, adding chloroform to completely dissolve the compound A, setting the temperature at 0-2 ℃, adding m-CPBA, heating to room temperature, and reacting overnight to obtain the compound B.
3. The preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the specific operation of step (2) is to take compound B and nitric acid solution according to a mass ratio of 1: 1-3, put compound B in concentrated sulfuric acid, stir uniformly, then add nitric acid solution at 0-2 ℃, heat up to room temperature, keep warm and react, and then heat up to react, thereby obtaining compound C.
4. The preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the specific operation in step (3) is to take the compound C and acetyl bromide in a mass ratio of 1: 6-10, mix the compound C and acetic acid in a solid-liquid g/mL ratio of 1:10, add acetyl bromide at 0 ℃, heat, stir and react to obtain the compound D.
5. The preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the step (4) comprises the specific steps of mixing the compound D and acetic anhydride in a mass ratio of 1: 2-4, carrying out nitrogen protection, heating, and reacting to obtain the compound E.
6. The method for producing 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the step (5) is specifically performed by mixing compound E and hydrochloric acid at a solid-liquid g/mL ratio of 1:10, and reacting to obtain compound F.
7. The preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein step (6) comprises mixing compound F and manganese dioxide at a mass ratio of 1: 4-6, placing in dichloromethane, and stirring for reaction to obtain compound G.
8. The method for preparing 4-bromo-2- (difluoromethyl) -5-methylpyridine according to claim 1, wherein the step (7) comprises the specific steps of placing the compound G in DCM, adding DAST 2-3 times the mass of the compound G, and stirring for reaction to obtain 4-bromo-2- (difluoromethyl) -5-methylpyridine.
CN202110860726.2A 2021-07-29 2021-07-29 Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine Pending CN113563258A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110860726.2A CN113563258A (en) 2021-07-29 2021-07-29 Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110860726.2A CN113563258A (en) 2021-07-29 2021-07-29 Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine

Publications (1)

Publication Number Publication Date
CN113563258A true CN113563258A (en) 2021-10-29

Family

ID=78168737

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110860726.2A Pending CN113563258A (en) 2021-07-29 2021-07-29 Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine

Country Status (1)

Country Link
CN (1) CN113563258A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115340492A (en) * 2022-09-26 2022-11-15 武汉海特生物创新医药研究有限公司 Preparation method of 2-hydroxy-4-amino-5-methylpyridine

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013093497A1 (en) * 2011-12-22 2013-06-27 Convergence Pharmaceuticals Limited 2 - (pyridin- 2yl) - 1, 7 -diaza- spiro [4.4] nonane- 6 -one compounds as voltage - gated sodium channels modulators
WO2018032586A1 (en) * 2016-08-15 2018-02-22 浙江永太科技股份有限公司 Method for synthesizing 3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxylic acid, and intermediates thereof
CN110981792A (en) * 2019-12-26 2020-04-10 阿里生物新材料(常州)有限公司 Synthetic method of [ (3-bromo-6-difluoromethyl) pyridin-2-yl ] methanol
CN112062712A (en) * 2020-09-25 2020-12-11 埃法姆药物研发(宁夏)有限公司 Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride
WO2021057975A1 (en) * 2019-09-29 2021-04-01 贝达药业股份有限公司 Mutant idh2 inhibitor and application thereof

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013093497A1 (en) * 2011-12-22 2013-06-27 Convergence Pharmaceuticals Limited 2 - (pyridin- 2yl) - 1, 7 -diaza- spiro [4.4] nonane- 6 -one compounds as voltage - gated sodium channels modulators
WO2018032586A1 (en) * 2016-08-15 2018-02-22 浙江永太科技股份有限公司 Method for synthesizing 3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxylic acid, and intermediates thereof
WO2021057975A1 (en) * 2019-09-29 2021-04-01 贝达药业股份有限公司 Mutant idh2 inhibitor and application thereof
CN110981792A (en) * 2019-12-26 2020-04-10 阿里生物新材料(常州)有限公司 Synthetic method of [ (3-bromo-6-difluoromethyl) pyridin-2-yl ] methanol
CN112062712A (en) * 2020-09-25 2020-12-11 埃法姆药物研发(宁夏)有限公司 Preparation method of 2- (5-bromo-3-methylpyridin-2-yl) acetic acid hydrochloride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘耀华著: "《有机化学中的选择性氧化作用》", 30 June 2008, 中国科学技术出版社 *
刘鹰翔: "《药物合成反应 新世纪第2版》", 31 August 2017, 中国中医药出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115340492A (en) * 2022-09-26 2022-11-15 武汉海特生物创新医药研究有限公司 Preparation method of 2-hydroxy-4-amino-5-methylpyridine

Similar Documents

Publication Publication Date Title
CN106699570B (en) Synthesis method of (2-chloro-5-iodophenyl) (4-fluorophenyl) ketone
CN110183378B (en) Nicotinamide derivative and catalytic synthesis method thereof
CN113563258A (en) Preparation method of 4-bromo-2- (difluoromethyl) -5-methylpyridine
CN107216289A (en) A kind of preparation method of Edaravone
CN106748721B (en) A kind of preparation method of the chloro- 5- iodo-benzoic acid of 2-
CN111662264B (en) Synthesis method of coumarin derivatives
CN108586493A (en) A kind of preparation method of crystal type CEFUROXIME AXETIL
CN115215782B (en) Preparation method of 4-bromoindole
CN1321972C (en) Process of preparing 4-nitro phthalic acid from the reaction mother liquor of nitrating phthalic anhydride to prepare 3-nitro phthalic acid
CN114181074B (en) Preparation method of p-chlorobenzoyl fluoride
CN105949176B (en) A kind of purification process of linatinib
CN106542958A (en) A kind of preparation method of adjacent Iodoaniline
CN111269094B (en) Preparation method of 2-bromo-1, 3-dimethoxybenzene
CN107011354A (en) A kind of preparation method of 5 Isosorbide Mononitrate
CN109761868B (en) Synthesis method of optically pure chlorprostenol
CN102010345A (en) Method for preparing D-phenylalanine through dynamic kinetic resolution
CN106045995A (en) Synthesizing method of 5-bromine-1H-pyrrolo[2,3-b]pyridine
CN103524439B (en) Method for preparing anastrozole
CN112574040B (en) Synthesis method of ethyl 2, 3-dichloro-4-nitrobenzoate
CN109134575B (en) Synthesis method of 3-carbonyl-6 alpha-hydroxy-5 beta-cholanic acid
CN112679361B (en) Synthetic method of 3-fluoro-5-nitropyridine-2-formaldehyde
CN102101849B (en) Preparation method of clausenamide intermediate
CN108822060B (en) 3-aryl substituted oxetane and preparation method thereof
CN111793010B (en) Preparation method of 2, 5-dichloro-4-aminobenzenesulfonyl fluoride
CN107573218A (en) A kind of method that solventing-out process improves bisphenol AF whiteness

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20211029

RJ01 Rejection of invention patent application after publication